The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry.

M Munera-CamposJ Vilar-AlejoR RiveraY José Manuel CarrascosaE DaudénE Herrera-AcostaA Sahuquillo-TorralbaF J Gómez-GarcíaO Baniandrés-RodríguezP de la CuevaJ L López-EstebaranzI BelinchónM FerranJ Riera-MonroigL RodriguezG CarreteroC García-DonosoF BallescáM Llamas-VelascoE Herrera-CeballosC Pujol-MarcoLula María Nieto-BenitoD P Ruiz-GenaoM AlsinaM A DescalzoI García-Dovalnull null

Published in: The Journal of dermatological treatment (2021)

Comparative information of the incidence of hepatic AEs could facilitate drug selection in moderate-to-severe psoriasis.

Keyphrases

drug induced
risk factors
early onset
high intensity
atopic dermatitis
health information
healthcare
emergency department
adverse drug